Candesartan antihypertensive survival evaluation in Japan (CASE-J) trial of cardiovascular events in high-risk hypertensive patients

Trial Profile

Candesartan antihypertensive survival evaluation in Japan (CASE-J) trial of cardiovascular events in high-risk hypertensive patients

Completed
Phase of Trial: Phase III

Latest Information Update: 17 Jan 2017

At a glance

  • Drugs Candesartan cilexetil (Primary) ; Amlodipine
  • Indications Cardiovascular disorders; Hypertension
  • Focus Therapeutic Use
  • Acronyms CASE-J; CASE-J Ex
  • Most Recent Events

    • 06 Sep 2013 Additional lead trial centres added as reported by University Hospital Medical Information Network - Japan record.
    • 01 Dec 2011 Extension study results published in Hypertension Research.
    • 29 Aug 2010 Effects of pre-existing type 2 diabetes and CHD on outcomes presented at the Annual Congress of the European Society of Cardiology (ESC) 2010 meeting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top